Adjuvant high-dose-rate and low-dose-rate brachytherapy with external beam radiation in soft tissue sarcoma: A comparison of outcomes

Brachytherapy ◽  
2007 ◽  
Vol 6 (1) ◽  
pp. 53-57 ◽  
Author(s):  
Surjeet Pohar ◽  
Rashid Haq ◽  
Lizhong Liu ◽  
Michael Koniarczyk ◽  
Seung Hahn ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Dose Rate ◽  
Low Dose ◽  
High Dose Rate ◽  
External Beam Radiation ◽  
High Dose ◽  
External Beam ◽  
Beam Radiation ◽  
Low Dose Rate ◽  
Low Dose Rate Brachytherapy

Perioperative high-dose-rate interstitial brachytherapy combined with external beam radiation therapy for soft tissue sarcoma

Brachytherapy ◽  
2015 ◽  
Vol 14 (4) ◽  
pp. 571-577 ◽  
Author(s):  
Daya Nand Sharma ◽  
S.V. Suryanarayana Deo ◽  
Goura Kisor Rath ◽  
Nootan Kumar Shukla ◽  
Sameer Bakhshi ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Dose Rate ◽  
High Dose Rate ◽  
External Beam Radiation Therapy ◽  
External Beam Radiation ◽  
High Dose ◽  
External Beam ◽  
Beam Radiation

scholarly journals Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy

2021 ◽  
pp. 854-860
Author(s):  
Toru Matsugasumi ◽  
Koji Masui ◽  
Kaori Yamada ◽  
Sho Watanabe ◽  
Koji Okihara ◽  
...  
Keyword(s):  
Dose Rate ◽  
Multimodal Treatment ◽  
Low Dose ◽  
High Dose Rate ◽  
External Beam Radiation Therapy ◽  
External Beam Radiation ◽  
High Dose ◽  
Secondary Cancer ◽  
Beam Radiation ◽  
Low Dose Rate

Prostate squamous cell carcinoma (pSCC) rarely develops as a secondary cancer after treatment with low-dose-rate brachytherapy (LDR-BT). There is no established effective treatment for the disease condition. Herein, we present a 78-year-old man who developed pSCC 8 years after LDR-BT. He was subsequently selected to receive a combined multimodal treatment with high-dose-rate interstitial brachytherapy (HDR-ISBT), external beam radiation therapy, and chemotherapy for his pSCC. Eleven months later, he displayed no biochemical failure nor clinical radiographic recurrence. However, MRI detected a newly developed prostatic-rectal fistula (grade 4), and a colostomy was performed to relieve pain and inflammation. To our knowledge, this is the first report to perform a combined multimodal treatment with HDR-ISBT for pSCC suspected as a secondary cancer due to LDR-BT.

Sign in / Sign up

Export Citation Format

Share Document